U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 227

1.
Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma
Songhe Guo, Fangfang Chen, Linfang Li, Shuheng Dou, Qifan Li, Yuying Huang, Zijun Li, Wanli Liu, Ge Zhang
J Adv Res. 2024 Jul; 61: 165–178. Published online 2023 Aug 22. doi: 10.1016/j.jare.2023.08.014
PMCID:
PMC11258656
AbstractArticlePDF–4.2M
2.
METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability
Huafu Li, Chunming Wang, Linxiang Lan, Leping Yan, Wuguo Li, Ian Evans, E. Josue Ruiz, Qiao Su, Guangying Zhao, Wenhui Wu, Haiyong Zhang, Zhijun Zhou, Zhenran Hu, Wei Chen, Joaquim M. Oliveira, Axel Behrens, Rui L. Reis, Changhua Zhang
Cell Mol Life Sci. 2022 Mar; 79(3): 135. Published online 2022 Feb 18. doi: 10.1007/s00018-022-04129-0
PMCID:
PMC11072755
AbstractArticlePDF–9.6M
3.
METTL3 recruiting M2-type immunosuppressed macrophages by targeting m6A-SNAIL-CXCL2 axis to promote colorectal cancer pulmonary metastasis
Peng Ouyang, Kang Li, Wei Xu, Caiyun Chen, Yangdong Shi, Yao Tian, Jin Gong, Zhen Bao
J Exp Clin Cancer Res. 2024; 43: 111. Published online 2024 Apr 11. doi: 10.1186/s13046-024-03035-6
PMCID:
PMC11007974
AbstractArticlePDF–6.8M
4.
Desulfovibrio desulfuricans and its derived metabolites confer resistance to FOLFOX through METTL3
Guifang Li, Huan Liu, Yangmeng Yu, Qian Wang, Chen Yang, Yang Yan, Fang Wang, Yong Mao
eBioMedicine. 2024 Apr; 102: 105041. Published online 2024 Mar 13. doi: 10.1016/j.ebiom.2024.105041
PMCID:
PMC10950750
AbstractArticlePDF–5.0M
5.
METTL3 as a novel diagnosis and treatment biomarker and its association with glycolysis, cuproptosis and ceRNA in oesophageal carcinoma
Xu‐Sheng Liu, Yu Zhang, Zi‐Yue Liu, Yan Gao, Ling‐Ling Yuan, Dao‐Bing Zeng, Fan Tan, Hua‐Bing Wan, Zhi‐Jun Pei
J Cell Mol Med. 2024 Mar; 28(6): e18195. Published online 2024 Mar 1. doi: 10.1111/jcmm.18195
PMCID:
PMC10907846
AbstractArticlePDF–17M
6.
The RNA m6A writer METTL3 in tumor microenvironment: emerging roles and therapeutic implications
Weiqi Su, Lin Che, Wenting Liao, Huilin Huang
Front Immunol. 2024; 15: 1335774. Published online 2024 Jan 22. doi: 10.3389/fimmu.2024.1335774
PMCID:
PMC10845340
AbstractArticlePDF–1.7M
7.
The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target
Xuming Zhou, Keqiang Chai, Hezhen Zhu, Cong Luo, Xiaofeng Zou, Junrong Zou, Guoxi Zhang
BMC Cancer. 2024; 24: 8. Published online 2024 Jan 2. doi: 10.1186/s12885-023-11741-1
PMCID:
PMC10762986
AbstractArticlePDF–1.7M
8.
METTL3-Dependent N6-Methyladenosine Modification Programs Human Neural Progenitor Cell Proliferation
Yuan Zhao, Jianguo Li, Yilin Lian, Qian Zhou, Yukang Wu, Jiuhong Kang
Int J Mol Sci. 2023 Nov; 24(21): 15535. Published online 2023 Oct 24. doi: 10.3390/ijms242115535
PMCID:
PMC10647291
AbstractArticlePDF–29M
9.
Intron retention decreases METTL3 expression by inhibiting mRNA export to the cytoplasm
Sangsoo Lee, Haesoo Jung, Sunkyung Choi, Namjoon Cho, Eun-Mi Kim, Kee Kwang Kim
BMB Rep. 2023 Sep 30; 56(9): 514–519. Published online 2023 Jul 3. doi: 10.5483/BMBRep.2023-0069
PMCID:
PMC10547966
AbstractArticlePDF–3.9M
10.
METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma
Kesong Shi, Rula Sa, Le Dou, Yuan Wu, Zhiqiang Dong, Xinyao Fu, Haiquan Yu
Clin Epigenetics. 2023; 15: 153. Published online 2023 Sep 23. doi: 10.1186/s13148-023-01568-9
Correction in:
Clin Epigenetics. 2024; 16: 2.
PMCID:
PMC10517543
AbstractArticlePDF–12M
11.
Expression and clinical significance of METTL3 in colorectal cancer
Hui Li, Zhilin Liu, Haitao Wang
Medicine (Baltimore) 2023 Sep 15; 102(37): e34658. Published online 2023 Sep 15. doi: 10.1097/MD.0000000000034658
PMCID:
PMC10508390
AbstractArticlePDF–941K
12.
Emerging role of METTL3 in inflammatory diseases: mechanisms and therapeutic applications
Bimei Song, Yue Zeng, Yanqing Cao, Jiamin Zhang, Chao Xu, Yaping Pan, Xida Zhao, Jingbo Liu
Front Immunol. 2023; 14: 1221609. Published online 2023 Aug 21. doi: 10.3389/fimmu.2023.1221609
PMCID:
PMC10475571
AbstractArticlePDF–1.1M
13.
METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis
Shaojun Chu, Yulong Li, Baojin Wu, Guo Rong, Qiang Hou, Qin Zhou, Dexiang Du, Yufei Li
Cell Transplant. 2023 Jan-Dec; 32: 09636897231188300. Published online 2023 Aug 22. doi: 10.1177/09636897231188300
PMCID:
PMC10467386
AbstractArticlePDF–4.3M
14.
METTL3 Mediates Epithelial–Mesenchymal Transition by Modulating FOXO1 mRNA N6‐Methyladenosine‐Dependent YTHDF2 Binding: A Novel Mechanism of Radiation‐Induced Lung Injury
Yang Feng, Ping Yuan, Hongjuan Guo, Liming Gu, Zhao Yang, Jian Wang, Wei Zhu, Qi Zhang, Jianping Cao, Lili Wang, Yang Jiao
Adv Sci (Weinh) 2023 Jun; 10(17): 2204784. Published online 2023 Apr 18. doi: 10.1002/advs.202204784
PMCID:
PMC10265050
AbstractArticlePDF–9.4M
15.
Increased METTL3 expression and m6A RNA methylation may contribute to the development of dry eye in primary Sjögren’s syndrome
Jun Ma, Xiaotang Wang, Xue Yang, Xi Wang, Tongshan Tan, Hongping Fang, Yu Zhong, Qi Zhang
BMC Ophthalmol. 2023; 23: 252. Published online 2023 Jun 5. doi: 10.1186/s12886-023-02988-0
PMCID:
PMC10243060
AbstractArticlePDF–1.4M
16.
Mettl3 Mediated m6A Methylation Involved in Epithelial-Mesenchymal Transition by Targeting SOCS3/STAT3/SNAI1 in Cigarette Smoking-Induced COPD
Yaping Zhang, Lixing Wang, Furong Yan, Meili Yang, Hongzhi Gao, Yiming Zeng
Int J Chron Obstruct Pulmon Dis. 2023; 18: 1007–1017. Published online 2023 May 30. doi: 10.2147/COPD.S398289
PMCID:
PMC10239240
AbstractArticlePDF–6.8M
17.
The Regulatory Network of METTL3 in the Nervous System: Diagnostic Biomarkers and Therapeutic Targets
Xiaojuan Su, Yi Qu, Dezhi Mu
Biomolecules. 2023 Apr; 13(4): 664. Published online 2023 Apr 11. doi: 10.3390/biom13040664
PMCID:
PMC10135467
AbstractArticlePDF–1.1M
18.
Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer
Yang Li, Shimiao Zhu, Yutong Chen, Qianwang Ma, Duo Kan, Wenyue Yu, Boya Zhang, Xuanrong Chen, Wanqing Wei, Yi Shao, Keruo Wang, Mingpeng Zhang, Shu Deng, Yuanjie Niu, Zhiqun Shang
Cell Death Dis. 2023 Apr; 14(4): 289. Published online 2023 Apr 24. doi: 10.1038/s41419-023-05773-5
PMCID:
PMC10126012
AbstractArticlePDF–7.5M
19.
Methyltransferase‐like 3 suppresses phenotypic switching of vascular smooth muscle cells by activating autophagosome formation
Ze‐Min Fang, Shu‐Min Zhang, Hanshen Luo, Ding‐Sheng Jiang, Bo Huo, Xiaoxuan Zhong, Xin Feng, Wenlin Cheng, Yue Chen, Gaoke Feng, Xingliang Wu, Fang Zhao, Xin Yi
Cell Prolif. 2023 Apr; 56(4): e13386. Published online 2022 Dec 23. doi: 10.1111/cpr.13386
PMCID:
PMC10068948
AbstractArticlePDF–5.8M
20.
METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy
Yueqin Sun, Weitao Shen, Shulu Hu, Qiong Lyu, Qiongyao Wang, Ting Wei, Weiliang Zhu, Jian Zhang
J Exp Clin Cancer Res. 2023; 42: 65. Published online 2023 Mar 17. doi: 10.1186/s13046-023-02638-9
PMCID:
PMC10022264
AbstractArticlePDF–17M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center